Ute Hengenbart

44PUBLICATIONS
144CO-AUTHORS
AnaesthesiologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jun 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

|Jun 10, 2026
First-Generation TTR Silencing Therapies in Hereditary Transthyretin Amyloidosis With Polyneuropathy: Real-World Insights From a German Single-Referral Center.

|Jun 08, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

|Mar 12, 2026
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis.

Stephan A Kaeser, Stephanie A Schultz, Anna Hofmann

|Mar 07, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.

George S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar

|Nov 13, 2025
Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis.

Selina J Hein, Fabian Aus dem Siepen, Arnt V Kristen

Pageof 8

Frequent Collaborators

24 joint publications

Stefan Schönland

8 joint publications

Vaishali Sanchorawala

8 joint publications

Morie Gertz

8 joint publications

Giovanni Palladini